GORDON EMPEY

Gordon Empey is a highly respected Partner at Frazier Healthcare Partners, a prominent private equity firm dedicated to investing in and building successful healthcare companies. Since joining Frazier in 2007, Mr. Empey has been instrumental in shaping the firm's investment strategy and driving value creation across its diverse portfolio. His deep industry knowledge and strategic acumen make him a key figure in the healthcare investment landscape.

As a Partner, Gordon Empey is actively involved in all stages of the investment lifecycle, from deal sourcing and due diligence to portfolio company management and exit strategies. His investment focus is broad yet specialized, encompassing critical areas within healthcare. This includes healthcare services, where he seeks innovative models improving patient care and operational efficiency; medical devices, targeting technologies that enhance diagnostics and treatment; and pharmaceutical services, supporting companies that facilitate drug development and delivery. He also has experience in areas like healthcare IT and life sciences, aligning with Frazier's comprehensive approach to healthcare innovation.

Prior to his tenure at Frazier Healthcare Partners, Gordon Empey honed his financial expertise in the demanding environment of investment banking. He served in J.P. Morgan's Healthcare Investment Banking Group, where he gained invaluable experience in mergers and acquisitions, capital raising, and strategic advisory for a wide range of healthcare clients. This foundational experience provided him with a robust understanding of market dynamics and corporate finance within the healthcare sector. Mr. Empey's strong academic background includes an MBA from the Stanford Graduate School of Business and a BA from Dartmouth College, further solidifying his analytical and leadership capabilities.

Throughout his career at Frazier, Gordon Empey has been involved with numerous successful investments that have made significant impacts in their respective fields. He played a key role in the growth of companies such as OrthoPediatrics, a leader in pediatric orthopedic implants, which successfully completed an initial public offering. He was also involved with Apollo Endosurgery, a medical device company later acquired by Boston Scientific, demonstrating his ability to identify and nurture high-potential ventures. Other notable engagements include PCI Pharma Services, a leading pharmaceutical contract development and manufacturing organization, and Solis Mammography, a prominent provider of breast screening and diagnostic services. These examples highlight his commitment to backing companies that deliver both strong financial returns and meaningful contributions to healthcare.

Gordon Empey's contributions to Frazier Healthcare Partners and the broader healthcare investment community are substantial. His strategic vision, coupled with a deep understanding of healthcare market trends, continues to drive successful outcomes for investors and innovation within the healthcare industry.